SERPINA1 and chronic obstructive pulmonary disease: The higher EIA/AAT ratio observed in this group, and especially in the two patients with severe comorbidities, suggests that the additional mechanisms involving other antiproteases may be stimulated by the same increased inflammatory state associated with the development of comorbidities in COPD [32].